BackVistagen Therapeutics Overview

Vistagen Therapeutics Net Income

Profitability analysis for VTGN.

Quarterly Net Income

-$18.90M
↓ 34.14% YoY

As of Dec 2025

Annual Net Income (TTM)

-$67.05M
↓ 41.73% YoY

Trailing 12 months ending Dec 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin